Sano blog | Sano Marketing Team (24)

precision medicine thought leadership

Driving innovation: The role of policy in precision medicine

Precision medicine is transforming healthcare by tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. Our latest ...

rare disease genetic testing podcast recap

Podcast recap: Pioneering tRNA therapies with Michelle Werner

In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had a fascinating conversation with Michelle Werner, CEO of Alltrna and CEO/Partner at Fla...

public health genetic testing health equity

Implementing genomics: Key strategies for early detection in at-risk populations

To fully harness the potential of genomics for early detection and prevention in at-risk populations, a comprehensive and strategic approach is crucial. Below, ...

precision medicine genetic testing population health

Exploring the future of genomics in healthcare: Early detection and prevention strategies for at-risk populations

Genomics has come a long way since the first human genome was sequenced in 2003. Today, sequencing a genome is not only faster but also significantly more affor...

precision medicine podcast recap

The Genetics Podcast recap: Exploring the microbiome's influence on personalised medicine with Almut Heinken

In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Almut Heinken, a junior professor at the INSERM Institut...

patient recruitment rare disease patient engagement

Webinar recap: Alpha-1 Antitrypsin Deficiency engagement, screening, and retention

In this webinar, "Alpha-1 Antitrypsin Deficiency: Engagement, screening, and retention," Sano Senior Project Manager, Hayley Holt, shares a case study on our wo...

podcast recap population health health equity

The Genetics Podcast recap: Championing diversity and accessibility in genomics with Mavis Machirori

In the latest episode of the Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Mavis Machirori, a senior researcher at the Ada Lovelace...

overview of fda guidance on natural history studies - social

rare disease protocol design

Navigating FDA guidance on natural history studies

Developing treatments for rare diseases involves unique obstacles due to the rarity and complexity of these conditions. To address these challenges, the FDA off...

thought leadership patient engagement

Passion and purpose: Celebrating Clinical Trials Day at Sano

In honour of Clinical Trials Day, we're sharing some reflections from our team at Sano about why we do what we do. Clinical Trials Day marks the anniversary of ...